Why Europe’s CDMO Sector Must Learn to Dance with Disruption
For CDMOs, the storms of de-industrialization, Brexit, and the Biosecure Act are not existential threats but the very winds that can propel them forward.
False
For CDMOs, the storms of de-industrialization, Brexit, and the Biosecure Act are not existential threats but the very winds that can propel them forward.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
April 11, 2025
3 min read
In the ever volatile, highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.
March 6, 2025
3 min read
And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.
March 10, 2025
3 min read
From geopolitical conflicts to cyber threats, CDMOs must rethink resilience.
March 26, 2025
3 min read
With competition for skilled employees in cell and gene therapy manufacturing high, companies need to ensure they are investing in training and mentorship.
False
Affiliations:
Specialties:
Areas of Expertise: